COLITIS, ULCERATIVE
Clinical trials for COLITIS, ULCERATIVE explained in plain language.
Never miss a new study
Get alerted when new COLITIS, ULCERATIVE trials appear
Sign up with your email to follow new studies for COLITIS, ULCERATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New gut bacteria treatment for ulcerative colitis shows promise in early trial
Disease control TerminatedThis study tested a new medicine called VE202 in people with mild-to-moderate ulcerative colitis, a condition that causes inflammation and sores in the colon. The goal was to see if VE202 could reduce inflammation and improve symptoms compared to a placebo. The trial was stopped …
Matched conditions: COLITIS, ULCERATIVE
Phase: PHASE2 • Sponsor: Vedanta Biosciences, Inc. • Aim: Disease control
Last updated May 26, 2026 02:53 UTC
-
New pill for ulcerative colitis shows promise in early trial
Disease control TerminatedThis study tested whether a daily tablet called VTX002 is safe and effective for people with moderate to severe ulcerative colitis. About 213 participants were planned to receive one of two doses of VTX002 or a placebo for up to 36 months. The trial was terminated early, so final…
Matched conditions: COLITIS, ULCERATIVE
Phase: PHASE2 • Sponsor: Oppilan Pharma Ltd • Aim: Disease control
Last updated May 26, 2026 02:47 UTC
-
Ulcerative colitis drug study halted early: what we know
Disease control TerminatedThis study looked at how safe and effective ozanimod is for people with moderate to severe ulcerative colitis, and how it affects their quality of life. About 139 participants were planned, but the study was stopped early. The goal was to see if the drug could reduce symptoms lik…
Matched conditions: COLITIS, ULCERATIVE
Phase: PHASE4 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 26, 2026 02:47 UTC